Examining the role of macrolides and host immunity in combatting filarial parasites

Parasit Vectors. 2017 Apr 14;10(1):182. doi: 10.1186/s13071-017-2116-6.

Abstract

Macrocyclic lactones (MLs), specifically the avermectins and milbemycins, are known for their effectiveness against a broad spectrum of disease-causing nematodes and arthropods in humans and animals. In most nematodes, drugs in this class induce paralysis, resulting in starvation, impaired ability to remain associated with their anatomical environment, and death of all life stages. Initially, this was also thought to be the ML mode of action against filarial nematodes, but researchers have not been able to validate these characteristic effects of immobilization/starvation of MLs in vitro, even at higher doses than are possible in vivo. Relatively recently, ML receptor sites exclusively located proximate to the excretory-secretory (ES) apparatus were identified in Brugia malayi microfilaria and an ML-induced suppression of secretory protein release by B. malayi microfilariae was demonstrated in vitro. It is hypothesized here that suppression of these ES proteins prevents the filarial worm from interfering with the host's complement cascade, reducing the ability of the parasite to evade the immune system. Live microfilariae and/or larvae, thus exposed, are attacked and presented to the host's innate immune mechanisms and are ultimately killed by the immune response, not the ML drug. These live, exposed filarial worms stimulate development of innate, cellular and humoral immune responses that when properly stimulated, are capable of clearing all larvae or microfilariae present in the host, regardless of their individual sensitivity to MLs. Additional research in this area can be expected to improve our understanding of the relationships among filarial worms, MLs, and the host immune system, which likely would have implications in filarial disease management in humans and animals.

Keywords: Avermectin; Brugia malayi; Brugia timori; Dirofilaria immitis; ES proteins; Excretory-secretory apparatus; Filarial worms; Immunity; Ivermectin; Macrocyclic lactones; Macrolides; Milbemycin; Onchocerca cervicalis; Onchocerca volvulus; Wuchereria bancrofti.

Publication types

  • Review

MeSH terms

  • Animals
  • Anthelmintics / pharmacology*
  • Biological Transport / drug effects
  • Brugia malayi / drug effects*
  • Brugia malayi / immunology*
  • Disease Models, Animal
  • Filariasis / parasitology*
  • Host-Pathogen Interactions / drug effects*
  • Humans
  • Macrolides / pharmacology*

Substances

  • Anthelmintics
  • Macrolides